Genmab | GEN - Assets

Stock Price
1,832.50
Daily Change
-21.00 -1.13%
Monthly
-13.15%
Yearly
14.67%
Q1 Forecast
1,757.86

Genmab reported DKK6.46B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Almirall EUR 2.31B 88.74M Jun/2025
Amarin USD 659.81M 10.31M Sep/2025
Amgen USD 90.59B 445M Dec/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Demant DKK 39.07B 6.43B Dec/2025
Exelixis USD 2.84B 20.87M Dec/2025
Fresenius Medical Care EUR 30.89B 404.18M Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GN Store Nord DKK 29.23B 170M Dec/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Insmed USD 2.26B 96.18M Dec/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024